Intra-Cellular Therapies, Inc. Business Finance Contracts & Agreements

15 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Release replacing the version included in each executive office
Release Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
2024
Underwriting Agreement, dated April 17, 2024, by and among the Company, J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2024
Underwriting Agreement, dated January 4, 2022, by and among the Company, J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2022
Underwriting Agreement, dated September 10, 2020, by and among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and SVB Leerink LLC, as representatives of the...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2020
Form of Stock Option Agreement under the 2019 Inducement Award Plan
Stock Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
2020
Form of Restricted Stock Unit Agreement under the 2019 Inducement Award Plan
Stock Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated January 7, 2020, by and among the Company, J.P. Morgan Securities LLC and SVB Leerink LLC, as representatives of the several underwriters named...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated September 27, 2017, by and among the Company, J.P. Morgan Securities LLC and Leerink Partners LLC, as representatives of the several underwriters...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2017
INTRA-CELLULAR THERAPIES, INC. 7,935,000 Shares of Common Stock (Including 1,035,000 Option Shares) Underwriting Agreement
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2015
INTRA-CELLULAR THERAPIES, INC. 5,462,500 Shares of Common Stock (Including 712,500 Option Shares) Underwriting Agreement
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2015
INTRA-CELLULAR THERAPIES, INC. Shares of Common Stock Underwriting Agreement
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2014
INTRA-CELLULAR THERAPIES, INC. REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2013
AMENDMENT OF INTRA-CELLULAR THERAPIES, INC. WARRANT TO PURCHASE COMMONSTOCK
Warrant Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
2013
INTRA-CELLULAR THERAPIES, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
DE
2013
Signature(s) Guaranteed: Medallion Guarantee Stamp
Guarantee Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
2013